Biogen Inc. buy Morgan Stanley
Start price
11.10.23
/
50%
€252.00
Target price
11.10.24
€339.70
Performance (%)
-15.12%
Price
17:44
€213.90
Summary
This prediction is currently active. The price of Biogen Inc. has decreased since the start of the prediction. Compared to the start price this results in a performance of -15.12%. This prediction currently runs until 11.10.24. The prediction end date can be changed by Morgan_Stanley at any time. Morgan_Stanley has 50% into this predictionPerformance without dividends (%)
Name | 1w | 1m |
---|---|---|
Biogen Inc. | -0.144% | -0.144% |
iShares Core DAX® | -0.612% | 0.567% |
iShares Nasdaq 100 | -3.018% | -3.205% |
iShares Nikkei 225® | -2.647% | 0.330% |
iShares S&P 500 | -1.932% | -1.126% |
Comments by Morgan_Stanley for this prediction
In the thread Biogen Inc. diskutieren
Biogen Inc. (NASDAQ: BIIB) had its price target lowered by analysts at Morgan Stanley from $381.00 to $361.00. They now have an "overweight" rating on the stock.
Ratings data for BIIB provided by MarketBeat